Pazobrite 200 mg Tablet 30's
₹4273.02*
MRP ₹5211
18% off
₹4429*
MRP ₹5211
15% CB
₹782 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Pazobrite 200 mg Tablet belongs to the group of medicine called ‘anti-cancer’ that is primarily indicated in the treatment of kidney and soft tissue cancer. Kidney cancer also known as renal cancer is a disease in which healthy cells of the kidney become malignant (cancerous), grow in an uncontrolled manner and forms a tumor. When a group of cancer occurs in different parts of the body such as bones, muscles, deep layers of skin, and fat then it is known as soft tissue sarcomas. This type of cancer may also form in nerves, blood vessels or connective tissues that support organs of the body.
Pazobrite 200 mg Tablet contains 'Pazopanib' which falls in the category of medicines known as 'kinase inhibitors'. It works by stopping the action of an abnormal protein that causes the multiplication of cancerous cells. In this way, it stops the spread of cancerous cells.
Take Pazobrite 200 mg Tablet as prescribed by your doctor. You are suggested to take Pazobrite 200 mg Tablet as long as your doctor has prescribed it after checking your medical condition. In some cases, you may experience certain common side effects such as itching or skin rash, acne, dry skin, vomiting, diarrhea and loss of appetite. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.
To treat your condition effectually, continue taking Pazobrite 200 mg Tablet for as long as your doctor has prescribed. Do not take Pazobrite 200 mg Tablet if you are pregnant or planning for pregnancy as Pazobrite 200 mg Tablet causes serious birth defects. Pazobrite 200 mg Tablet should not be taken by breastfeeding mothers as it passes into breast milk and may cause possible risk to the infant. Elderly people are more sensitive to medicine so the doctor may adjust the dosage according to the condition. Avoid consuming alcohol along with Pazobrite 200 mg Tablet as it could lead to increased dizziness.
Pazobrite 200 mg Tablet is a ' tyrosine kinase inhibitor (TKI)', that stops the uncontrolled growth and spread of cancerous cells. Pazobrite 200 mg Tablet is effective in treating thyroid, liver and kidney cancer. It acts by stopping the action of the abnormal protein that is responsible for the multiplication of cancerous cells. Whenever a new healthy cell is formed it undergoes a usual process of maturity. Cancerous cells form new cells more quickly so Pazobrite 200 mg Tablet targets cancerous cells and blocks the action of Tyrosine kinases enzymes (responsible for causing cancer). It also decreases the blood supply to cancer tumors to slow down the growth of the tumor. In this way, Pazobrite 200 mg Tablet stops the production, spread and growth of cancerous cells in the body.
Pazobrite 200 mg Tablet may make you more susceptible to infections; consult your doctor if you develop any signs of infections such as fever, sore throat, breathlessness, jaundice, unexplained bleeding or bruising. Your doctor may advise you to undergo regular blood tests, kidney and liver tests to monitor your condition. Inform your doctor about your health condition and medicines to rule out any unpleasant side-effects. Before your doctor prescribes you Pazobrite 200 mg Tablet , tell them if you have heart problems, high blood pressure, bleeding issues, surgery or an electrolyte imbalance (like abnormal levels of magnesium, calcium or potassium in the blood). Pazobrite 200 mg Tablet is restricted to use in persons who are sensitive to any of its constituents or have squamous cell lung cancer or already taking carboplatin and paclitaxel.
Drug-Drug Interaction: Pazobrite 200 mg Tablet may have interaction with anti-cancer medicine (Sorafenib and Paclitaxel), antibiotics (Neomycin), anti-seizure medicine (carbamazepine, phenytoin), an antacid (Omeprazole).
Drug-Food Interaction: The absorption of Pazobrite 200 mg Tablet gets reduced in presence of food. This is why it is suggested to take Pazobrite 200 mg Tablet on an empty stomach or 1 or 2 hours after a meal. Additionally, an individual should avoid grapefruit juice as it may increase the amount of drug in the bloodstream.
Drug-Disease Interaction: Do not take Pazobrite 200 mg Tablet if you have squamous cell lung cancer.
Cancer: It is a genetic change in which our cells divide uncontrollably and spread into surrounding tissues. There are two types of cancer, namely benign (localized) and metastatic (spread to the whole body). There are more than 100 types of cancer, including blood cancer, lung cancer, breast cancer, etc. Cancer growth can be prevented by chemotherapy (by strong antibiotics), radiation and stem cell therapy.
Renal cancer: Kidneys help to get rid of waste by filtering blood, regulate fluid balance, and helps in making urine. Kidney cancer occurs when cancerous cells start growing uncontrollably in the kidneys.
Soft tissue sarcoma: It is a disease in which cancerous cells form in the soft tissues of the body such as a deep layer of skin, fat, muscles and bones. This type of cancer can also form in nerves, blood vessels or tissues that support organs of the body. This type of cancer is most common in the neck, arms, legs, abdomen and legs.
Alcohol
Unsafe
You are recommended to avoid alcohol consumption with Pazobrite 200 mg Tablet as it may increase the risk of side effects such as dizziness, drowsiness or difficulty in concentrating.
Pregnancy
Unsafe
Pazobrite 200 mg Tablet is restricted to use in pregnancy. A woman needs to have a negative pregnancy test before starting treatment with this medicine. It is better to use effective birth control methods to prevent pregnancy while taking this medicine or for at least 6 months after taking the last dose of Pazobrite 200 mg Tablet .
Breast Feeding
Unsafe
Pazobrite 200 mg Tablet should not be taken by breastfeeding mothers as it passes into breast milk and may cause possible risk to the infant.
Driving
Caution
It is not known if Pazobrite 200 mg Tablet may affect your driving ability or not.
Liver
Safe if prescribed
Pazobrite 200 mg Tablet should be taken with caution in patients dealing with the liver disease. The dose may be adjusted by the doctor according to the medical condition of the patient.
Kidney
Safe if prescribed
Pazobrite 200 mg Tablet is safe to take by patients dealing with kidney cancer as prescribed by their doctor. The dose may be adjusted by the doctor according to the medical condition of the patient.
Children
Unsafe
Pazobrite 200 mg Tablet is not recommended for children below 18 years as the safety and effectiveness were not established.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information
Product Substitutes